Global Commercial (Conventional and Biotech/GM) Seeds Market Size By Type (Maize, Soybean), By Application (Agricultural, Research institution), By Region, And Segment Forecasts, 2023 to 2032

The Global Commercial (Conventional and Biotech/GM) Seeds Market was valued at USD 62.4 billion in 2023 and is projected to reach USD 109.7 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031). This growth is propelled by increasing food demand, advancements in genetic engineering, and the widespread adoption of high-yield crop varieties to ensure food security. The market includes both conventional seeds developed through selective breeding and biotech/GM seeds created through genetic modification, addressing diverse agricultural needs globally.

Drivers:

1. Rising Demand for High-Yield and Stress-Resistant Crops:

Farmers are increasingly adopting commercial seeds that offer better productivity and resilience against drought, pests, and diseases. Biotech/GM seeds have been instrumental in minimizing crop loss and optimizing yields.

2. Expanding Global Population and Food Demand:

A growing global population is intensifying pressure on agricultural output. Commercial seeds, especially GM variants, are vital in closing the food supply-demand gap.

3. Supportive Government Initiatives and Technological Advancements:

Various government subsidies for hybrid seed usage and biotech R&D funding are boosting market penetration, especially in emerging economies.

Restraints:

1. Regulatory and Environmental Concerns:

Stringent regulations, especially concerning GM seed approval and labeling, can slow down product rollouts and affect market access in some regions.

2. High Initial Costs and Dependency:

The cost of genetically modified seeds can be significantly higher than conventional ones. Additionally, contractual obligations with biotech seed providers can lead to farmer dependency and reduced seed-saving practices.

Opportunity:

1. Expansion into Emerging Markets:

Africa, Southeast Asia, and Latin America represent untapped growth regions with increasing awareness and investment in agricultural technology.

2. Innovations in Crop Biotechnology:

Emerging gene-editing technologies (e.g., CRISPR) and synthetic biology are paving the way for the next generation of commercial seeds, enabling custom traits such as enhanced nutrition and reduced input needs.

Market by System Type Insights:

Based on seed type, the Biotech/GM Seeds segment led the market in 2023 due to its superior performance under adverse climatic and biotic stress conditions. Genetically engineered seeds offering herbicide tolerance and insect resistance are widely used for crops like maize, soybean, and cotton. However, the Conventional Seeds segment remains essential for organic and traditional farming practices and continues to hold significant market share in several regions.

Market by End-use Insights:

By end-use, the Cereal & Grains segment dominated the market in 2023, led by high adoption of hybrid and GM corn and rice seeds. Demand for high-quality grains for food and biofuel production supports this segment’s growth. The Fruits & Vegetables segment is also growing rapidly, driven by the global trend toward healthy eating and year-round produce demand.

Market by Regional Insights:

Geographically, North America accounted for the largest share of the global market in 2023, backed by extensive adoption of GM crops, supportive biotech regulations, and strong R&D infrastructure. Asia-Pacific is projected to grow at the fastest pace, with countries like India and China increasing investments in agricultural innovation and yield optimization. Meanwhile, Latin America continues to expand its GM crop cultivation, particularly in Brazil and Argentina.

Competitive Scenario:

Leading players in the Global Commercial Seeds Market include Bayer AG, Corteva Agriscience, Syngenta AG, Limagrain, KWS Saat SE, DLF Seeds A/S, Sakata Seed Corporation, and Rijk Zwaan. These companies invest heavily in biotechnology research, seed variety development, and expansion into high-growth markets. For example:

In 2023, Bayer AG introduced a new GM corn seed with triple-stacked traits offering pest and herbicide resistance.

In 2024, Corteva launched drought-tolerant maize hybrids tailored for sub-Saharan Africa.

In 2025, Syngenta announced strategic partnerships with agri-tech startups to advance digital farming integration with GM seeds.

Scope of Work – Global Commercial (Conventional and Biotech/GM) Seeds Market

Key Market Developments:

2023: Bayer AG released a new line of herbicide-resistant soybeans for Latin American markets.

2024: Limagrain introduced climate-adaptive wheat hybrids across Europe.

2025: KWS Saat SE expanded its biotech seed R&D facility in North America to focus on next-gen trait development.

FAQs:

1) What is the current market size of the Global Commercial (Conventional and Biotech/GM) Seeds Market?

The market was valued at USD 62.4 billion in 2023.

2) What is the major growth driver of the Global Commercial (Conventional and Biotech/GM) Seeds Market?

The major driver is the rising global demand for high-yield, stress-resistant crops amid growing food needs.

3) Which is the largest region during the forecast period in the Global Commercial (Conventional and Biotech/GM) Seeds Market?

North America leads due to widespread GM crop adoption and biotech innovation.

4) Which segment accounted for the largest market share in the Global Commercial (Conventional and Biotech/GM) Seeds Market?

The Biotech/GM Seeds segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Commercial (Conventional and Biotech/GM) Seeds Market?

Key players include Bayer AG, Corteva Agriscience, Syngenta AG, Limagrain, and KWS Saat SE.

Let me know if you'd like this converted to a downloadable Word document or if you need a report on another topic.